← SynDRA
somatostatin
SynDRA canonical compound SYN0041827 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | SSTR5 |
|---|
| Mechanism of action | Somatostatin receptor agonist |
|---|
| Indication | hemorrhage |
|---|
| Disease area | hematology |
|---|
All known targets
- SSTR5
- SSTR1
- SSTR2
- SSTR4
- SSTR3
- OPRD1
- OPRM1
- Sstr4
- Sstr3
- Sstr2
- Sstr1
- GH1
Mechanisms of action (all sources)
- Somatostatin receptor agonist
- SSTR5 AGONIST
- SSTR2 AGONIST
- SSTR4 AGONIST
- SSTR1 AGONIST
- SSTR3 AGONIST
- SSR2 AGONIST
- SSR4 AGONIST
- SSR1 AGONIST
- SSR3 AGONIST
- OPRM1 INHIBITOR
- SSTR2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA1A
- SLC6A2
- HRH2
- ABCB1
- HTR3A
- GCGR
- GHSR
- HDAC6
- HRH1
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR6
- EDNRB
- HTR7
- KCNH2
- MC3R
- MC4R
- NPY1R
- NPY2R
- SLC6A3
- SLC6A4
- TACR2
- GABBR1
- EDNRA
- ADORA1
- CCKAR
- ADORA2A
- ADORA3
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- BDKRB1
- BDKRB2
- CCKBR
Drug classes
ATC classes
- H01C · HYPOTHALAMIC HORMONES
Cross-references
Synonyms
- aminopan
- growth hormone release-inhibiting factor
- somatotropin release-inhibiting hormone
- SRIF-14
- Somatostatine
- Somatostatina
- Somatostatin-14
- SST-14
- SS14
- Somiaton
- Panhibin
- Aminopan
- Somatostatin acetate
- SRIF
- Somatotropin release-inhibiting factor
- Somatotropin release-inhibiting hormone
- Growth hormone release inhibiting factor
- CCRIS 7071
- EINECS 256-969-7
- Growth hormone release-inhibiting hormone
- AY 24910
- Somatostatin 1-14
- Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys
- NCGC00181005-01
- [D-Trp8]-SOMATOSTATIN
- SCHEMBL3046327
- Cyclic Somatostatin
- Somatostatin 14
- Somatostatinum
- Somatostatin, cyclic
- Synthetic somatostatin-14
- Somatostatin-1
- 6E20216Q0L
- CHEBI:64628
- Somatotropin release inhibiting factor
- DTXCID6026793
- SRIH-14
Look up somatostatin in the interactive SynDRA portal →